Jointown Pharmaceutical Group Co Ltd
Jointown Pharmaceutical Group Co., Ltd engages in pharmaceutical distribution and supply chain business in China and internationally. It is also involved in general agency brand promotion; pharmaceutical industrial self-production and OEM; and pharmaceutical new retail and ten-thousand store alliance plan businesses. In addition, the company provides medical health and technology value-added serv… Read more
Market Cap & Net Worth: Jointown Pharmaceutical Group Co Ltd (600998)
Jointown Pharmaceutical Group Co Ltd (SHG:600998) has a market capitalization of $3.65 Billion (CN¥26.78 Billion) as of March 19, 2026. Listed on the SHG stock exchange, this China-based company holds position #5601 globally and #746 in its home market, demonstrating a 2.71% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Jointown Pharmaceutical Group Co Ltd's stock price CN¥5.31 by its total outstanding shares 5042470234 (5.04 Billion).
Jointown Pharmaceutical Group Co Ltd Market Cap History: 2015 to 2026
Jointown Pharmaceutical Group Co Ltd's market capitalization history from 2015 to 2026. Data shows change from $5.38 Billion to $3.65 Billion (-2.99% CAGR).
Jointown Pharmaceutical Group Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Jointown Pharmaceutical Group Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.02x
Jointown Pharmaceutical Group Co Ltd's market cap is 0.02 times its annual revenue
0.29x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
1.40x
Jointown Pharmaceutical Group Co Ltd's market cap is 1.40 times its annual earnings
9.21x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $5.38 Billion | $49.59 Billion | $694.53 Million | 0.11x | 7.75x |
| 2016 | $5.76 Billion | $61.56 Billion | $876.74 Million | 0.09x | 6.56x |
| 2017 | $5.26 Billion | $73.94 Billion | $1.45 Billion | 0.07x | 3.64x |
| 2018 | $4.09 Billion | $87.14 Billion | $1.34 Billion | 0.05x | 3.05x |
| 2019 | $4.00 Billion | $99.50 Billion | $1.73 Billion | 0.04x | 2.32x |
| 2020 | $5.14 Billion | $110.86 Billion | $3.08 Billion | 0.05x | 1.67x |
| 2021 | $4.35 Billion | $122.41 Billion | $2.45 Billion | 0.04x | 1.78x |
| 2022 | $4.00 Billion | $140.42 Billion | $2.08 Billion | 0.03x | 1.92x |
| 2023 | $4.82 Billion | $150.14 Billion | $2.17 Billion | 0.03x | 2.22x |
| 2024 | $3.52 Billion | $151.81 Billion | $2.51 Billion | 0.02x | 1.40x |
Competitor Companies of 600998 by Market Capitalization
Companies near Jointown Pharmaceutical Group Co Ltd in the global market cap rankings as of March 19, 2026.
Key companies related to Jointown Pharmaceutical Group Co Ltd by market ranking:
- McKesson Corporation (NYSE:MCK): Ranked #165 globally with a market cap of $115.21 Billion USD.
- Cencora Inc. (NYSE:COR): Ranked #350 globally with a market cap of $62.31 Billion USD.
- Cardinal Health Inc (NYSE:CAH): Ranked #430 globally with a market cap of $50.81 Billion USD.
- Sigma Healthcare Limited (OTCGREY:SIGGF): Ranked #1462 globally with a market cap of $12.16 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #165 | McKesson Corporation | NYSE:MCK | $115.21 Billion | $941.89 |
| #350 | Cencora Inc. | NYSE:COR | $62.31 Billion | $334.71 |
| #430 | Cardinal Health Inc | NYSE:CAH | $50.81 Billion | $216.36 |
| #1462 | Sigma Healthcare Limited | OTCGREY:SIGGF | $12.16 Billion | $1.88 |
Jointown Pharmaceutical Group Co Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, Jointown Pharmaceutical Group Co Ltd's market cap moved from $5.38 Billion to $ 3.65 Billion, with a yearly change of -2.99%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥3.65 Billion | +3.71% |
| 2025 | CN¥3.52 Billion | 0.00% |
| 2024 | CN¥3.52 Billion | -26.96% |
| 2023 | CN¥4.82 Billion | +20.54% |
| 2022 | CN¥4.00 Billion | -8.18% |
| 2021 | CN¥4.35 Billion | -15.30% |
| 2020 | CN¥5.14 Billion | +28.34% |
| 2019 | CN¥4.00 Billion | -1.98% |
| 2018 | CN¥4.09 Billion | -22.32% |
| 2017 | CN¥5.26 Billion | -8.63% |
| 2016 | CN¥5.76 Billion | +6.99% |
| 2015 | CN¥5.38 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Jointown Pharmaceutical Group Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $3.65 Billion USD |
| MoneyControl | $3.65 Billion USD |
| MarketWatch | $3.65 Billion USD |
| marketcap.company | $3.65 Billion USD |
| Reuters | $3.65 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.